Health Care & Life Sciences » Pharmaceuticals | China Resources Double-Crane Pharmaceutical Co. Ltd.

China Resources Double-Crane Pharmaceutical Co. Ltd. A | Mutual Funds

Mutual Funds that own China Resources Double-Crane Pharmaceutical Co. Ltd. A

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
40,375,409
4.9%
21,834,004
8.1%
12/31/2017
HSBC Jintrust Large Cap Equity Fund
34,033,940
4.13%
12,112,330
8.82%
12/31/2017
8,304,478
1.01%
1,385,298
4.99%
12/31/2017
LC Value Discovery Equity Fund
4,918,117
0.6%
1,590,395
1.43%
12/31/2017
Value Partners Intelligent Funds - China Convergence Fund
4,647,691
0.56%
4,647,691
3.32%
12/31/2017
4,575,431
0.56%
4,287,431
0.53%
12/31/2017
HSBC Jintrust Long Teng Equity Fund
3,614,488
0.44%
48,484
5.29%
12/31/2017
3,141,546
0.38%
3,141,546
2.43%
12/31/2017
2,966,371
0.36%
0
3.54%
12/31/2017
2,248,638
0.27%
1,096,638
1.3%
12/31/2017

About China Resources Double-Crane Pharmaceutical Co.

View Profile
Address
No. 1 Lize East 2nd Road
Beijing Beijing 100102
China
Employees -
Website http://www.dcpc.com
Updated 07/08/2019
China Resources Double-Crane Pharmaceutical Co., Ltd. engages in the drug development, manufacturing, and sale. It focuses on injection, cardiovascular and cerebrovascular, endocrinology, and pediatric field. It specializes in slow disease general medicine business, specialist business, and infusion business.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.